Clinical Trials Browser

OTHER × Uterine Cervical Neoplasms × trametinib × Clear all

NCT01958112 2019-05-31

GSK1120212+GSK2141795 for Cervical Cancer

Phase 2 Terminated

14 enrolled 10 charts

Uterine Cervical Neoplasms